CARI is a collaboration between The Centre for Probe Development and Commercialization (CPDC) and adMare BioInnovations (adMare) where we will bring respective resources together to advance an area of tremendous therapeutic and commercial potential in which Canada can gain considerable global competitive advantage: RADIOPHARMACEUTICALS. The objective of CARI is for CPDC and adMare to seek out and uncover radiopharmaceutical opportunities arising from academic discoveries and early enterprises, establish rigorous drug development programs around selected opportunities, and drive the generation of proof-of-principle and other data supportive of the commercialization of new radiopharmaceutical assets.
Biologics Validation & Support
Chemistry Manufacturing & Controls
Radiochemistry Research Consultation
Commercialization & IP Strategies
To learn more about CARI download our presentation:
Still have Questions? Consult our FAQ or watch our webinar recording:
Let us know about your project and how CARI can help accelerate your agent to the next level. To submit an application please fill out the following form.
The role of radiopharmaceuticals in health care may still be quite a mystery for many Canadians, but this area has a tremendous therapeutic and commercial potential. The Centre for Probe Development Commercialization and adMare BioInnovations present you with a series of blogs about radiopharmaceuticals as part of CARI, a collaboration between the two organizations to advance this area in Canada.